Four updates:
1. Surveillance: The percentage of laboratory specimens testing positive for COVID-19 with a molecular assay increased in seven of 10 HHS surveillance regions for the week ending Aug. 29. This figure decreased in the Southeast, South West/West Coast and Pacific Northwest regions.
2. Mortality: About 6.6 percent of deaths nationwide were attributed to flu, pneumonia or COVID-19 in the week ending Aug. 29. This figure marks a decline from the week prior but is still above the epidemic threshold.
3. Hospitalizations: The cumulative hospitalization rate for all age groups increased to 161 per 100,000 population in the week ending Aug 29.
4. Outpatient activity: The percentage of ED visits for COVID-19-like symptoms decreased nationally for the seventh straight week and fell in all 10 regions compared to a week prior. The percentage of outpatient visits for flu-like illness also decreased or held steady in every region.
More articles on public health:
A timeline of emerging infectious diseases in history
COVID-19 antibodies may last 4 months, Iceland study finds
Connecticut hospital COVID-19 cases tied to nursing home outbreak
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
